Prize

Awarding a European prize is equivalent to a validation of the Technology readiness level (TRL) of the project by an independent body (European commission: Executive Agency for Small and Medium-sized Enterprises – EASME).

2017 H2020 SME INSTRUMENT phase-2 Topic :SMEInst-03-2017. European commission

 

2015 H2020 SME INSTRUMENT phase-1 Topic : BIOTEC-5a2015. European commission

 

2015 17th i-Lab “Créadev” BPI France

 

2013 15th “émergence” OSEO/BPI

 

2013 – Innovation Days One of 15 finalists “Innovation Prize” Universal Biotech.

Contact Info

Laboratory
Parc scientifique Biocitech
102 Avenue Gaston Roussel
Batiment Pasteur Secteur 2169
93230 Romainville - France

Office
56 Boulevard de la Mission Marchand - 92400 Courbevoie France

Phone: +33 1 43 34 89 90

Mobile: +33 6 60 90 41 24

2020 – B SMART – SMALL IS SMART

Regulaxis’ President Claude Carelli  participated to the  interview on B SMART
The 1st meeting dedicated to small and medium-sized businesses.

At the microphone of Jean-Marc Sylvestre, Claude Carelli expose Regulaxis activity, their strategy, their needs and objectives.

 

A program in partnership with BPI France at 1 p.m. and 8:30 p.m. on B SMART.

July 7th, 2020|0 Comments

PLOS ONE – Publication

Regulaxis is proud to announce the publication to the In Vivo study, on rat model of traumatic knee osteoarthritis, conducted in collaboration with Artialis SA, on PLOS ONE journal.

July 3rd, 2020|0 Comments

Seal of Excellence – Certificate delivered by the European Commission – Horizon 2020

Following evaluation by an international panel of independent experts, Regulaxis research was scored as a high-quality project proposal in a highly competitive evaluation process.

This proposal is recommended for funding by other sources, since Horizon 2020 resources available for this specific Call were already allocated following a competitive ranking.

The project proposal:  “REG-O3 Treatment of gonarthrosis […]

July 3rd, 2020|0 Comments

2019 – Vancouver, Canada – 15th World Congress of ICRS

Regulaxis is proud to present the recent results on the effectiveness of REG-O3 in a model of traumatic knee osteoarthitis.

“REG-O3 Chimeric Peptide combining Growth Hormone and Somatostatin sequences slows down Traumatic Knee Osteoarthritis Progression in Rat”
Rodrick Montjean, Sonia Escaich, Raffaello Paolini, Claude Carelli, Yves Henrotin, Christelle Vêtu

July 3rd, 2020|0 Comments

2019 – Le Figaro Economie – RDV PME

Regulaxis’ President Claude Carelli and the COO Christelle Vêtu participated to the RDV PME by Le Figaro Economie
This interview is focused on the research and development in the field of bioscience. In particular Regulaxis present a new innovative compound, REGO3, for the treatment of arthroses.

 

Follow the full article to Le Figaro Economie

 

July 10th, 2019|0 Comments

2019 – Sendai, Japan – EU-Japan Industrial Cooperation

Regulaxis is very proud to be the only French company selected by the EU-Japan Industrial Cooperation Center to be part of the European delegation !
Thank you also to Miyagi province officials and Jetro for receiving us and meeting top industrial companies in Sendai.

 

Dr. Matthieu Chareyre, our Executive Director of Industrial Operations, represented Regulaxis to this […]

May 30th, 2019|0 Comments

2019 – Milan, Italy – “Outsourcing in Clinical Trials Europe”

 

Regulaxis’ President and CEO Claude Carelli and the CSO Christelle Vêtu participated to the OCT conference in Europe, in Milan, Italy, on May 14-15.

Follow us to http://regulaxis.com/news/

May 14th, 2019|0 Comments

2019 – Toronto, Canada – OARSI World Congress

REGULAXIS is at the 2019 OARSI conference in Toronto from 2nd-5th of May !

OARSI World Congress on Osteoarthritis: Doctor Christelle Vêtu, CSO and Strategic Business Advisor will present the latest results during the poster session : “Chimeric Peptide combining both Growth Hormone and Somatostatin Sequences (REG-O3) improves function and prevents cartilage degradation in rat […]

May 2nd, 2019|0 Comments

2019 – Paris, France – ANRT – CLUB PME – ETI

Lors de la séance du 8 Avril du CLUB PME – ETI Claude CARELLI, Président et CEO de Regulaxis a présenté son entreprise et son « business model ». Les membres du Club l’ont « challengé » pour qu’il récolte le fruit de ce «brainstorming » collectif.
Engagée dans la R&D, Regulaxis développe des molécules […]

April 8th, 2019|0 Comments

2018 – Regulaxis moves to La Défense !

The offices of the Regulaxis Management Office are located at the feet of La Défense, the business district located in the Metropole du Grand Paris.

December 10th, 2018|0 Comments